加拿大核科学家与制药公司合作,利用辐射开发新的癌症治疗。 Canadian nuclear scientists join drug firms to develop new cancer treatments using radiation.

加拿大核实验室(CNL)与 " Repare治疗和防御治疗 " 生物制药公司合作,研究新的癌症治疗方法。 Canadian Nuclear Laboratories (CNL) has teamed up with biopharmaceutical firms Repare Therapeutics and Defence Therapeutics to research new cancer treatments. 这些项目是CNL2021年启动的CNRI-H方案的一部分,其重点是有针对性的放射药物,通过了解辐射如何影响癌症细胞的DNA修复,改善癌症治疗。 The projects, part of CNL's 2021-launched CNRI-H program, focus on targeted radiopharmaceuticals to improve cancer therapies by understanding how radiation affects DNA repair in cancer cells. 这项合作旨在为癌症患者制定更有效的治疗方法。 This collaboration aims to develop more effective treatments for cancer patients.